(FOXA) Fox - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US35137L1052
Stock:
Total Rating 43
Risk 52
Buy Signal -0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 29.2% |
| Relative Tail Risk | -6.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -11.74 |
| Character TTM | |
|---|---|
| Beta | 0.581 |
| Beta Downside | 0.831 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.29% |
| CAGR/Max DD | 0.67 |
EPS (Earnings per Share)
Revenue
Description: FOXA Fox
Fox Corporation operates as a news, sports, and entertainment company in the United States. It operates in four segments: Cable Network Programming, Television, Credible, and The FOX Studio Lot. The Cable Network Programming segment produces and licenses news and sports content for distribution through traditional cable television systems, direct broadcast satellite operators, telecommunication companies, virtual multi-channel video programming distributors, and other digital platforms. Its Television segment produces, acquires, markets, and distributes programming through the FOX broadcast network, advertising-supported video-on-demand service Tubi, and operates full power broadcast television stations, including duopolies and other digital platforms. This segment also produces content for third parties. The Credible segment engages in the consumer finance marketplace. Its FOX Studio Lot segment provides television and film production services along with office space, studio operation services, and all operations of the facility. Fox Corporation was incorporated in 2018 and is headquartered in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 1.89b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.83 > 1.0 |
| NWC/Revenue: 26.00% < 20% (prev 32.54%; Δ -6.54% < -1%) |
| CFO/TA 0.13 > 3% & CFO 2.73b > Net Income 1.89b |
| Net Debt (6.33b) to EBITDA (3.35b): 1.89 < 3 |
| Current Ratio: 2.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (441.0m) vs 12m ago -4.55% < -2% |
| Gross Margin: 33.06% > 18% (prev 0.84%; Δ 3222 % > 0.5%) |
| Asset Turnover: 74.52% > 50% (prev 65.94%; Δ 8.58% > 0%) |
| Interest Coverage Ratio: 7.74 > 6 (EBITDA TTM 3.35b / Interest Expense TTM 382.0m) |
Altman Z'' 3.16
| A: 0.20 (Total Current Assets 6.73b - Total Current Liabilities 2.42b) / Total Assets 21.47b |
| B: 0.18 (Retained Earnings 3.78b / Total Assets 21.47b) |
| C: 0.13 (EBIT TTM 2.96b / Avg Total Assets 22.25b) |
| D: 0.35 (Book Value of Equity 3.66b / Total Liabilities 10.35b) |
| Altman-Z'' Score: 3.16 = A |
Beneish M -1.63
| DSRI: 0.93 (Receivables 3.56b/3.49b, Revenue 16.58b/15.18b) |
| GMI: 2.53 (GM 33.06% / 83.58%) |
| AQI: 1.07 (AQ_t 0.57 / AQ_t-1 0.53) |
| SGI: 1.09 (Revenue 16.58b / 15.18b) |
| TATA: -0.04 (NI 1.89b - CFO 2.73b) / TA 21.47b) |
| Beneish M-Score: -1.63 (Cap -4..+1) = CCC |
What is the price of FOXA shares?
As of February 25, 2026, the stock is trading at USD 55.98 with a total of 2,639,064 shares traded.
Over the past week, the price has changed by -0.80%, over one month by -23.02%, over three months by -12.94% and over the past year by -2.57%.
Over the past week, the price has changed by -0.80%, over one month by -23.02%, over three months by -12.94% and over the past year by -2.57%.
Is FOXA a buy, sell or hold?
Fox has received a consensus analysts rating of 3.59.
Therefor, it is recommend to hold FOXA.
- StrongBuy: 8
- Buy: 1
- Hold: 11
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the FOXA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.9 | 33.9% |
| Analysts Target Price | 74.9 | 33.9% |
FOXA Fundamental Data Overview February 21, 2026
P/E Trailing = 13.4676
P/E Forward = 12.7226
P/S = 1.4411
P/B = 2.1935
P/EG = 14.1334
Revenue TTM = 16.58b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 3.35b USD
Long Term Debt = 6.60b USD (from longTermDebt, last quarter)
Short Term Debt = 42.0m USD (from shortTermDebt, last quarter)
Debt = 8.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.33b USD (from netDebt column, last quarter)
Enterprise Value = 30.22b USD (23.89b + Debt 8.34b - CCE 2.02b)
Interest Coverage Ratio = 7.74 (Ebit TTM 2.96b / Interest Expense TTM 382.0m)
EV/FCF = 11.92x (Enterprise Value 30.22b / FCF TTM 2.54b)
FCF Yield = 8.39% (FCF TTM 2.54b / Enterprise Value 30.22b)
FCF Margin = 15.30% (FCF TTM 2.54b / Revenue TTM 16.58b)
Net Margin = 11.41% (Net Income TTM 1.89b / Revenue TTM 16.58b)
Gross Margin = 33.06% ((Revenue TTM 16.58b - Cost of Revenue TTM 11.10b) / Revenue TTM)
Gross Margin QoQ = 22.91% (prev 41.63%)
Tobins Q-Ratio = 1.41 (Enterprise Value 30.22b / Total Assets 21.47b)
Interest Expense / Debt = 1.17% (Interest Expense 98.0m / Debt 8.34b)
Taxrate = 23.29% (75.0m / 322.0m)
NOPAT = 2.27b (EBIT 2.96b * (1 - 23.29%))
Current Ratio = 2.78 (Total Current Assets 6.73b / Total Current Liabilities 2.42b)
Debt / Equity = 0.76 (Debt 8.34b / totalStockholderEquity, last quarter 10.93b)
Debt / EBITDA = 1.89 (Net Debt 6.33b / EBITDA 3.35b)
Debt / FCF = 2.49 (Net Debt 6.33b / FCF TTM 2.54b)
Total Stockholder Equity = 11.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.50% (Net Income 1.89b / Total Assets 21.47b)
RoE = 16.22% (Net Income TTM 1.89b / Total Stockholder Equity 11.66b)
RoCE = 16.20% (EBIT 2.96b / Capital Employed (Equity 11.66b + L.T.Debt 6.60b))
RoIC = 12.33% (NOPAT 2.27b / Invested Capital 18.41b)
WACC = 6.21% (E(23.89b)/V(32.23b) * Re(8.06%) + D(8.34b)/V(32.23b) * Rd(1.17%) * (1-Tc(0.23)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.35%
[DCF] Terminal Value 87.34% ; FCFF base≈2.26b ; Y1≈2.78b ; Y5≈4.74b
[DCF] Fair Price = 591.3 (EV 125.00b - Net Debt 6.33b = Equity 118.67b / Shares 200.7m; r=6.21% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 37.66 | EPS CAGR: 0.33% | SUE: 1.57 | # QB: 11
Revenue Correlation: 41.08 | Revenue CAGR: 11.42% | SUE: 1.54 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.98 | Chg7d=-0.174 | Chg30d=-0.175 | Revisions Net=-11 | Analysts=16
EPS current Year (2026-06-30): EPS=4.64 | Chg7d=+0.019 | Chg30d=+0.165 | Revisions Net=+10 | Growth EPS=-3.0% | Growth Revenue=-0.0%
EPS next Year (2027-06-30): EPS=5.18 | Chg7d=+0.006 | Chg30d=+0.112 | Revisions Net=+5 | Growth EPS=+11.7% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: -0.73 (2 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 8.1% - Earnings Yield 7.4%)
[Growth] Growth Spread = -13.5% (Analyst -12.8% - Implied 0.6%)
P/E Forward = 12.7226
P/S = 1.4411
P/B = 2.1935
P/EG = 14.1334
Revenue TTM = 16.58b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 3.35b USD
Long Term Debt = 6.60b USD (from longTermDebt, last quarter)
Short Term Debt = 42.0m USD (from shortTermDebt, last quarter)
Debt = 8.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.33b USD (from netDebt column, last quarter)
Enterprise Value = 30.22b USD (23.89b + Debt 8.34b - CCE 2.02b)
Interest Coverage Ratio = 7.74 (Ebit TTM 2.96b / Interest Expense TTM 382.0m)
EV/FCF = 11.92x (Enterprise Value 30.22b / FCF TTM 2.54b)
FCF Yield = 8.39% (FCF TTM 2.54b / Enterprise Value 30.22b)
FCF Margin = 15.30% (FCF TTM 2.54b / Revenue TTM 16.58b)
Net Margin = 11.41% (Net Income TTM 1.89b / Revenue TTM 16.58b)
Gross Margin = 33.06% ((Revenue TTM 16.58b - Cost of Revenue TTM 11.10b) / Revenue TTM)
Gross Margin QoQ = 22.91% (prev 41.63%)
Tobins Q-Ratio = 1.41 (Enterprise Value 30.22b / Total Assets 21.47b)
Interest Expense / Debt = 1.17% (Interest Expense 98.0m / Debt 8.34b)
Taxrate = 23.29% (75.0m / 322.0m)
NOPAT = 2.27b (EBIT 2.96b * (1 - 23.29%))
Current Ratio = 2.78 (Total Current Assets 6.73b / Total Current Liabilities 2.42b)
Debt / Equity = 0.76 (Debt 8.34b / totalStockholderEquity, last quarter 10.93b)
Debt / EBITDA = 1.89 (Net Debt 6.33b / EBITDA 3.35b)
Debt / FCF = 2.49 (Net Debt 6.33b / FCF TTM 2.54b)
Total Stockholder Equity = 11.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.50% (Net Income 1.89b / Total Assets 21.47b)
RoE = 16.22% (Net Income TTM 1.89b / Total Stockholder Equity 11.66b)
RoCE = 16.20% (EBIT 2.96b / Capital Employed (Equity 11.66b + L.T.Debt 6.60b))
RoIC = 12.33% (NOPAT 2.27b / Invested Capital 18.41b)
WACC = 6.21% (E(23.89b)/V(32.23b) * Re(8.06%) + D(8.34b)/V(32.23b) * Rd(1.17%) * (1-Tc(0.23)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.35%
[DCF] Terminal Value 87.34% ; FCFF base≈2.26b ; Y1≈2.78b ; Y5≈4.74b
[DCF] Fair Price = 591.3 (EV 125.00b - Net Debt 6.33b = Equity 118.67b / Shares 200.7m; r=6.21% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 37.66 | EPS CAGR: 0.33% | SUE: 1.57 | # QB: 11
Revenue Correlation: 41.08 | Revenue CAGR: 11.42% | SUE: 1.54 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.98 | Chg7d=-0.174 | Chg30d=-0.175 | Revisions Net=-11 | Analysts=16
EPS current Year (2026-06-30): EPS=4.64 | Chg7d=+0.019 | Chg30d=+0.165 | Revisions Net=+10 | Growth EPS=-3.0% | Growth Revenue=-0.0%
EPS next Year (2027-06-30): EPS=5.18 | Chg7d=+0.006 | Chg30d=+0.112 | Revisions Net=+5 | Growth EPS=+11.7% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: -0.73 (2 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 8.1% - Earnings Yield 7.4%)
[Growth] Growth Spread = -13.5% (Analyst -12.8% - Implied 0.6%)